Globus Medical ( (GMED) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Globus Medical shares are moving as investors react to bullish signals from across the medtech sector, sparked by a strong earnings beat and a raised 2026 outlook from peer Edwards Lifesciences. Traders are also positioning ahead of Globus Medical’s own Q1 earnings report on May 7, adding speculative pressure to the stock.
Analyst sentiment has turned more favorable, with the stock recently upgraded to a Zacks Rank #1, or Strong Buy. The company has also revised its 2026 earnings guidance upward, giving analysts and investors more confidence in its long‑term growth path even as the stock comes under short‑term pressure.
More about Globus Medical
YTD Price Performance: 3.93%
Average Trading Volume: 1,092,900
Technical Sentiment Signal: Buy
Current Market Cap: $12.65B
For further insights into GMED stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.